Plasma exchange or immunoadsorption in patients with rapidly progressive crescentic glomerulonephritis: A Swedish multi-center study

International Journal of Artificial Organs

Volumn 22, Issue 2, 1999, Pages 81-87

  Stegmayr, Bernd G ^a   Almroth, G ^b   Berlin, G ^b   Fehrman, I ^b   Kurkus, J ^b   Norda, R ^b   Olander, R ^b   Sterner, G ^b   Thysell, H ^b   Wikstrom B ^b   Wiren J E ^b  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Glomerulonephritis; Immunoadsorption; Plasma exchange; Randomized

Indexed keywords

ANTIBODIES; PATIENT TREATMENT;

AS SUBSTITUTIONS; GLOMERULONEPHRITIS; IMMUNOADSORPTION; MULTI-CENTRE STUDY; OBSERVATION PERIOD; PLASMA EXCHANGES; PROSPECTIVES; RANDOMIZED; RENAL FUNCTIONS; SWEDISHS;

DIALYSIS;

CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISOLONE; STEROID;

ADULT; AGED; ARTICLE; DIALYSIS; FEMALE; GOODPASTURE SYNDROME; HUMAN; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; ORAL DRUG ADMINISTRATION; PLASMAPHERESIS; PROSPECTIVE STUDY; SWEDEN; TREATMENT OUTCOME;

EID: 0032902702     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139889902200205     Document Type: Article

References (29)

1. Serra A, Cameron JS, Turner DR, et al. Vasculitis affecting the kidney. Presentation histopathology and long term outcome. Q J Med 1984; 270: 181-207.
2. Coward RA, Hamdy NAT, Shortland JS, Brown CB. Renal micropolyarteritis: a treatable condition. Nephrol Dial Transplant 1986; 1:31-7.
3. Jacquot C, Baran D, Vendeville B, Pelletier L, Druet P. Update on immunosuppressive therapy in human and experimental glomerulonephritis. Adv Nephrol 1986, 17: 77-100.
4. Fuiano G, Cameron JS, Raftery M, Hartley BH, Williams DG, Ogg CS. Improved prognosis of renal microscopic polyarteritis in recent years. Nephrol Dial Transplant 1988, 3: 383-91.
5. Falk RJ, Hogan S, Carey TS, Jennette JC. Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network. Ann Intern Med 1990; 113: 656-63.
6. Adu D, Pall A, Luqmani RA, et al. Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. Q J Med 1997; 90: 401-9.
7. Sieberth HG, Maurin N. The therapy of rapidly progressive glomerulonephritis. Klin Wochenschr 1983; 61(20): 1001-10.
8. Pusey CD, Lockwood CM, Peters DK. Plasma exchange and immunosuppressive drugs in the treatment of glomerulonephritis due to antibodies to the glomerular basement membrane. Int J Artif Organs 1983; 6: 15-8.
9. Lockwood CM, Pincing AJ, Sweny P. Plasma-exchange and immunosuppression in the treatment of fulminating immune complex crescentic nephritis. Lancet 1977; i : 63-7.
10. Stevens ME, McConnell M, Bone JM. Aggressive treatment with pulse methylprednisolone or plasma exchange is justified in rapidly progressive glomerulonephritis. Proc EDTA 1982; 19: 724-31.
11. Rifle G, Dechelette E. Treatment of rapid progressive glomerulonephritis by plasma exchange and methylprednisolone pulses. A prospective randomized trial of cyclophosphamide. Interim analysis. The French Cooperative Group. Prog Clin Biol Res 1990; 337: 263-7.
12. Pusey CD, Rees AJ, Evans DJ, Peters DK, Lockwood CM. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 1991; 40(4): 757-63.
13. Levy JB, Pusey CD. Still a role for plasma exchange in rapidly progressive glomerulonephritis? J Nephrol 1997; 10: 7-13.
14. Glöckner WM, Sieberth HG, Wichmann HE, et al. Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: a controlled, multi-center study Clin Nephrol 1988; 29: 1-8.
15. Cole E, Cattran D, Magil A, the Canadian Apheresis Study Group, et al. A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. The Canadian Apheresis Study Group. Am J Kidney Dis 1992; 20 (3): 261-9.
16. Bygren P, Freiburghaus C, Lindholm T. Goodpasture's syndrome treated with staphylococcal protein A immunoadsorption. Lancet 1985; ii: 1295-6.
17. Mockrzycki MH, Kaplan AA. Therapeutic plasma exchange: complications and management. Am J Kidney Dis 1994; 23: 817-27.
18. Falk RJ, Jennette JC. A nephrological view of the classification of vasculitis. Adv Exp Med Biol 1993; 336: 197-208.
19. Samuelsson G. Immunoadsorption using the Excorim® treatment system. Transfus Sci 1998; 19:3-4.
20. Saxena R, Isaksson B, Bygren P, Wieslander J. A rapid assay for circulating anti-glomerular basement membrane antibodies in Goodpasture syndrome. J Immunol Methods 1989; 118: 73-8.
21. Wieslander J. How are ANCA detected? Am J Kidney Dis 1991; 27: 154-8.
22. Siersbaek-Nielsen K, Hansen JM, Kampmann J, Kristensen M. Rapid evaluation of creatinine clearance. Lancet 1971; 1(7709): 1133-4.
23. ™, Version 2.04, SAS Institute, Cary, NC. USA.
24. ® is more effective than plasma exchange in reducing IgG. Abstract L-068. World Apheresis Association 6th International Congress, Florence Nov. 1996. Florence, Italy: Scientific Press.
25. Segelmark M, Elzouki A-N, Wieslander J, Eriksson S. The PiZ gene of alfa1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. Kidney Int 1995; 48: 844-50.
26. Stegmayr B, Cedergren B, Nilsson T, Lindqvist B, Sondell K, Lindström S. On the use of liquid stored or cryoprecipitate-poor plasma in plasma exchange. An alternative to fresh frozen plasma. In: Bambauer R, Malchesky PS, Falkenhagen D eds. Therapeutic Plasma Exchange and Selective Plasma Separation. International Symposium, Homburg/Saar, FRG, June 18-20, 1985. Schattauer, Stuttgart, New York, 1987: 339-42.
27. Rondeau E, Levy M, Dosquet P, Ruedin P, Mougenot B, Kanfer A, Sraer JD. Plasma exchange and immunosuppression for rapid progressive glomerulonephritis: prognosis and complications. Nephrol Dial Transplant 1989; 4(3): 196-200.
28. Stegmayr B. Successful effect on renal function in proliferative glomerulonephritis by early treatment with plasma exchange and immunosuppression. In: Bambauer R, Malchesky PS, Falkenhagen D, eds. Therapeutic Plasma Exchange and Selective Plasma Separation. International Symposium, Homburg/Saar, FRG, June 18-20, 1985. Schattauer, Stuttgart, New York, 1987: 77-80.
29. Norda RAC. For the Swedish Apheresis Group. Therapeutic hemapheresis in Sweden 1992-1995. Abstract L015. World Apheresis Association 6th International Congress, Florence Nov. 1996. Florence, Italy: Scientific Press.